[{"address1": "333 Las Olas Way", "address2": "CU4 Suite 433", "city": "Fort Lauderdale", "state": "FL", "zip": "33301", "country": "United States", "phone": "(954) 330-0684", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 72, "title": "Chairman, President & CEO", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 1291587, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 65, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 352031, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 366625, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 39, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michel  Roy", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 62, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.48, "open": 1.48, "dayLow": 1.4501, "dayHigh": 1.525, "regularMarketPreviousClose": 1.48, "regularMarketOpen": 1.48, "regularMarketDayLow": 1.4501, "regularMarketDayHigh": 1.525, "payoutRatio": 0.0, "beta": 0.402, "forwardPE": 0.0074989987, "volume": 34030, "regularMarketVolume": 34030, "averageVolume": 97817, "averageVolume10days": 46650, "averageDailyVolume10Day": 46650, "bid": 1.1, "ask": 1.92, "bidSize": 2, "askSize": 2, "marketCap": 6826164, "fiftyTwoWeekLow": 1.169, "fiftyTwoWeekHigh": 3.9, "priceToSalesTrailing12Months": 0.18783261, "fiftyDayAverage": 1.4771, "twoHundredDayAverage": 1.967285, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -2537121, "profitMargins": -0.17354, "floatShares": 4553895, "sharesOutstanding": 4555940, "sharesShort": 247990, "sharesShortPriorMonth": 295667, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0544, "heldPercentInsiders": 0.03167, "heldPercentInstitutions": 0.02853, "shortRatio": 5.5, "shortPercentOfFloat": 0.0545, "impliedSharesOutstanding": 4555950, "bookValue": 5.635, "priceToBook": 0.26589173, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -6306620, "trailingEps": -15.02, "forwardEps": 199.8, "lastSplitFactor": "1:20", "lastSplitDate": 1723075200, "enterpriseToRevenue": -0.07, "enterpriseToEbitda": 0.491, "52WeekChange": -0.46879435, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 1.4983, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 10305320, "totalCashPerShare": 2.262, "ebitda": -5165312, "totalDebt": 929026, "quickRatio": 2.492, "currentRatio": 4.997, "totalRevenue": 36341740, "debtToEquity": 3.617, "revenuePerShare": 14.633, "returnOnAssets": -0.11083999, "returnOnEquity": -0.2565, "grossProfits": 12112492, "freeCashflow": -7741418, "operatingCashflow": -7755505, "revenueGrowth": 0.012, "grossMargins": 0.33328998, "ebitdaMargins": -0.14213, "operatingMargins": -0.10551, "financialCurrency": "USD", "symbol": "SBFM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1644935400000, "postMarketChangePercent": 0.780887, "postMarketPrice": 1.51, "postMarketChange": 0.0117, "regularMarketChange": 0.018299937, "regularMarketDayRange": "1.4501 - 1.525", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 97817, "fiftyTwoWeekLowChange": 0.32929993, "fiftyTwoWeekLowChangePercent": 0.2816937, "fiftyTwoWeekRange": "1.169 - 3.9", "fiftyTwoWeekHighChange": -2.4017, "fiftyTwoWeekHighChangePercent": -0.6158205, "fiftyTwoWeekChangePercent": -46.879433, "dividendDate": 1586131200, "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -15.02, "epsForward": 199.8, "fiftyDayAverageChange": 0.021199942, "fiftyDayAverageChangePercent": 0.014352407, "twoHundredDayAverageChange": -0.46898508, "twoHundredDayAverageChangePercent": -0.23839204, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-15", "cryptoTradeable": false, "shortName": "Sunshine Biopharma Inc.", "longName": "Sunshine Biopharma, Inc.", "corporateActions": [], "postMarketTime": 1757719869, "regularMarketTime": 1757707200, "exchange": "NCM", "messageBoardId": "finmb_78729055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.2364823, "regularMarketPrice": 1.4983, "displayName": "Sunshine Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]